News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Neuroimmune Signaling Between the Heart and the Brain May Contribute to Heart Attack Damage
April 10, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
NIH-funded researchers found a harmful triple-node loop involved in heart attacks. Blocking any one of these three components reduced heart injury and improved heart function.
Read ArticleUNC Health, UNC-Chapel Hill Debut Platform for AI Development
April 8, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Asthma Drug Shows No Benefit for Mild to Moderate COVID-19, Study Finds
October 21, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
New FDA Designations May Jumpstart Gene Therapy Development
October 18, 2024 - NCATS News
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)
New FDA designations granted to NCATS for rare disease therapies provide financial incentives for companies to further develop treatments.
Can AI Shake-Up Translational Research?
October 16, 2024 - Media Coverage
- Biomedical Data Translator (Translator)
Men and Women Use Different Biological Systems to Reduce Pain
October 16, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Toxic Protein May Contribute to ALS Development
October 11, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
New Drug Screening Funnel Could Speed New Therapies for Gaucher Disease, Parkinson’s
October 11, 2024 - NCATS News
- Assay Development and Screening Technology (ADST)
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
A three-step drug-testing process created by NIH scientists and their partners could find new therapies faster for Gaucher disease and Parkinson’s disease.